Madagascar was certified free of wild poliovirus in June 2018 but since then has experienced outbreaks of type 1 variant polio. Between 2020 to 2023, 55 children in the country were paralyzed by the virus. But because of high-quality response activities, no new case has been reported since September 2023. This progress is thanks to the dedicated health workers who are committed to reaching every child with polio vaccines.
At the same time, the polio program recognizes that communities in Madagascar are facing numerous other health threats – neglected tropical diseases are chief among them. One of the most prevalent is lymphatic filariasis, commonly known as Elephantiasis, a disease caused by parasitic worms that can lead to extreme swelling of body parts, immense pain and severe disability. Infection is usually acquired during childhood, just like polio.
The good news is that its spread can be stopped by giving an annual dose of preventive chemotherapy to the at-risk population, a strategy called mass drug administration (MDA). The polio program, through its far-reaching house-to-house vaccination campaigns, has a lot of experience and infrastructure to do just that. The program is often a family’s only connection to the formal health system. As such, providing more services to these vulnerable households on each visit improves their trust in the program and health system, thus increasing the likelihood they will accept the vaccine.
Throughout 2023 and 2024, the Polio Coordination Team in Madagascar worked closely with the MDA Directorate to deliver this medicine alongside polio vaccines during their campaigns in response to the type 1 variant polio outbreak. The campaigns saw important improvements in coverage for both diseases. For example, during the last round of the 2023 campaign where 61 districts were targeted, only 2 had coverage lower than the 90-95% target for polio vaccination, and only 3 had coverage lower than the 65% target for MDA. In total, over 4.6 million children were protected from polio and lymphatic filariasis during the four rounds of the campaign in 2023. In the first and second rounds of the integrated campaign in 2024, about 1.4 million children were protected against polio and 1.2 million from lymphatic filariasis.
In addition to the ability to protect more children, there were also important financial savings for the health system. Thanks to the co-delivery of the two activities across 56 districts in 2023, there was an estimated cost savings of over US$ 1 million. In 2024, the integrated campaign in 15 districts was shown to have saved another US$ 172,000. Without integrating with the polio campaign, MDA would have likely been postponed for several months until adequate funds were mobilized, leaving thousands unprotected and vulnerable to the disease.
There are several key factors that have made these efforts so successful:
- Government Commitment: The Madagascar government was committed to co-delivering polio and MDA to improve access to healthcare for its population and deliver more with less resources.
- Strong Communication & Advocacy: The communications tools used during the campaigns by social mobilizers and the advocacy banners hung in communities also delivered integrated messages, including information on both polio and Elephantiasis.
- Centralized Coordination: A single coordinating body of representatives from the MDA Directorate and the Polio Coordination team was formed, enabling easy sharing of resources to monitor preparations, train healthcare workers, and deploy them in the field. Strengthening the relationship between these teams at all levels facilitated helpful information sharing of best practices, improving both programs.
- Agile Planning: The distribution of MDA was delayed by one day to ensure reduction of workload on the teams and assurance that any side effects could be monitored and correctly attributed.
The polio program in Madagascar, working closely with health authorities, will continue to optimize the delivery of other essential medicine and health services during campaigns. For example, a polio vaccination campaign in October 2024 also delivered measles vaccines to children.
As interruption of polio transmission gets closer in Madagascar, and outbreak response campaigns thus become less frequent, these efforts will increasingly focus on ways to strengthen routine immunization. Securing the resources and commitment to continue these efforts will be critical to both stopping polio now and building a stronger, more resilient health system to protect generations to come.